openPR Logo
Press release

Immunology Market to Witness Huge Growth by 2026 | Leading Key Players AbbVie Inc., Janssen Global Services, LLC (Johnson & Johnson), Amgen Inc., Pfizer Inc. and more

10-14-2019 11:42 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Fortune Business Insights

Immunology Market to Witness Huge Growth by 2026 | Leading Key

According to a report published by Fortune Business Insights, titled “IMMUNOLOGY Market Size, Share and Global Trend By Drug Class ( Monoclonal antibody (mAb), Fusion Proteins, Immunosuppressants, Polyclonal antibody (pAb), Others ), By Disease Indication ( Rheumatoid Arthritis, Psoriatic Arthritis, Plaque Psoriasis, Ankylosing Spondylitis, Inflammatory Bowel Disease, Prophylaxis of Organ Rejection, Others ), By Distribution Channel ( Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Geography Forecast till 2026: GLOBAL MARKET ANALYSIS, INSIGHTS AND FORECAST, 2019-2026,” the market was valued at US$ 77,365.4 Mn in 2018.
The Global Immunology Market is likely to expand in the coming years driven by the high prevalence of immunological disorders, resulting from environmental factors.

Browse Complete Report Details at
https://www.fortunebusinessinsights.com/industry-reports/immunology-market-100657
Fortune Business Insights has predicted that the market will reach US$ 143,833.2 Mn by 2026 and will exhibit a CAGR of 8.1%.

Some of the major companies that are present in the Global Immunology Market are;

• AbbVie Inc.
• Janssen Global Services, LLC (Johnson & Johnson)
• F. Hoffmann-La Roche Ltd
• Amgen Inc.
• Pfizer Inc.
• Novartis AG
• Astellas
• Bristol-Myers Squibb Company
• Merck Sharp & Dohme Corp.
• UCB SA
• ALLERGAN
• Other Prominent Players

The global immunology market is likely to expand in the coming years driven by the high demand for immunology drugs resulting from the high prevalence of immunological disorders. The severity of immunological disorders has created an increasing awareness around the world. Various initiatives and advisory programs have been conducted by the government as well as public organizations.
This, in turn, will fuel the demand for immunology drugs. Furthermore, the increased efficiency of immunology drugs has contributed to better patient outcomes, which in turn has led to subsequent growth of the global immunology market.

Get Sample PDF Brochure at
https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/immunology-market-100657

Segmentation for Immunology Market are;
By Drug Class
• Monoclonal antibody (mAb)
• Fusion Proteins
• Immunosuppressants
• Polyclonal antibody (pAb)
• Others
By Disease Indication
• Rheumatoid Arthritis
• Psoriatic Arthritis
• Plaque Psoriasis
• Ankylosing Spondylitis
• Inflammatory Bowel Disease
• Prophylaxis of Organ Rejection
• Others
By Distribution Channel
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Others
By Geography

Recent Product Approvals by Regulatory Agencies to Bode Well for the Overall Market
The spate of recent regulatory approvals for the immunology products is anticipated to contribute to the overall positive growth of the market. For instance, the recent regulatory approval and the subsequent launch of TREMFYA (Guselkumab) by Janssen Global Services, LLC (Johnson & Johnson), is expected to lead to better outcome for the patients. TREMFYA (Guselkumab) was launched for the treatment of moderate to severe plaque psoriasis, a seriously debilitating immunological disorder. TREMFYA is the only biologic approved for the treatment of moderate to severe plaque psoriasis, that selectively blocks the interleukin (IL)-23, leading to a vast improvement in the symptoms of the patient. Apart from being one of the emerging drugs of the immunology market, Fortune Business Insights predicts that Janssen Global Services, LLC (Johnson & Johnson) latest product offering will have a positive impact on the global immunology market in the forthcoming years.
AbbVie Gains FDA Approval of SKYRIZI; Product to Witness High Demand in No Time

The global immunology market has gained impetus from the availability of several regulatory approved drugs. The approval of new drugs and the trends of improvements in clinical efficiencies will bode well for the global immunology market. In 2019, AbbVie received approval from the Food and Drug Administration (FDA) for the usage of ‘SKYRIZI’. The drug was aimed at the treatment of moderate to severe plaque psoriasis. This drug was inclined towards the treatment of adults diagnosed with psoriasis and have been recommended for or undergoing therapy. The drug is likely to gain huge popularity among healthcare professionals and its high clinical efficacy will fuel the demand in the coming years.

Besides product launches and drug approvals, Fortune Business Insights assesses several other factors that have made significant growth contributions to the global immunology market. Companies are encouraged by the growing usage approvals by regulatory authorities across the world. Several company mergers and acquisitions have also accounted for growth of the global immunology market.

STRONG INDUSTRY FOCUS:
• Extensive product offerings
• Customer research services
• Robust research methodology
• Comprehensive reports
• Latest technological developments
• Value chain analysis
• Potential market opportunities
• Growth dynamics
• Quality assurance
• Post-sales support
• Regular report updates

Get Discount at
https://www.fortunebusinessinsights.com/enquiry/check-discount/immunology-market-100657

Fortune Business Insights Pvt. Ltd.
308, Supreme Headquarters,
Survey No. 36, Baner,
Pune-Bangalore Highway,
Pune - 411045, Maharashtra, India.
Phone:
US: +1 424 253 0390
UK: +44 2071 939123
APAC: +91 744 740 1245
Email: sales@fortunebusinessinsights.com

About Us:

Fortune Business Insights offers expert corporate analysis and accurate data, helping organizations of all sizes make timely decisions. We tailor innovative solutions for our clients, assisting them address challenges distinct to their businesses. Our goal is to empower our clients with holistic market intelligence, giving a granular overview of the market they are operating in.

Our reports contain a unique mix of tangible insights and qualitative analysis to help companies achieve sustainable growth. Our team of experienced analysts and consultants use industry-leading research tools and techniques to compile comprehensive market studies, interspersed with relevant data.

At Fortune Business Insights we aim at highlighting the most lucrative growth opportunities for our clients. We therefore offer recommendations, making it easier for them to navigate through technological and market-related changes. Our consulting services are designed to help organizations identify hidden opportunities and understand prevailing competitive challenges.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Immunology Market to Witness Huge Growth by 2026 | Leading Key Players AbbVie Inc., Janssen Global Services, LLC (Johnson & Johnson), Amgen Inc., Pfizer Inc. and more here

News-ID: 1848204 • Views:

More Releases from Fortune Business Insights

Reverse Flame Steam Boiler Market 2023 Dynamics, Major Players, SWOT Analysis, a …
Overview of the Global Reverse Flame Steam Boiler Market 2030: The report discusses everything a marketer requires before investing in the global Reverse Flame Steam Boiler Market during the forecast period 2023-2030. Reverse Flame Steam Boiler Market Size, Share And Global Trend By Capacity (Up to 100kW, 100-1000 kW, Above 1000 kW), By End-Use (Food Industry, Chemical Industry, Refineries, Metal Industry, Power Plant), And Geography Forecast Till 2022-2029. It provides detailed
Syngas and Derivatives Market Research Analysis, Size, Share, Growth Highlights …
Overview of the Global Syngas and Derivatives Market 2030: The report discusses everything a marketer requires before investing in the global Syngas and Derivatives Market during the forecast period 2023-2030. Syngas and Derivatives Market Size, Share and Global Trend By Feedstock(Coal, Petroleum, Natural Gas, Biomass), By Technology(Partial Oxidation, Steam Reforming, Auto-Thermal Reforming, and others), By End User(Chemicals, Power Generation, Liquid Fuels, Gaseous Fuels), and Geography Forecast till 2022-2029. It provides detailed
Port equipment Market Will Experience An Upswing In Demand, Driven By Top Players | Liebherr (Switzerland), TTS Group (Norway), Kalmar (Finland) Konecranes (Finland) |
Port equipment Market Will Experience An Upswing In Demand, Driven By Top Player …
The Port equipment Market Research Report provides an in-depth analysis of the market landscape and identifies future growth opportunities and trends until 2030. By offering valuable insights, the report enables companies to make informed decisions on business strategies and identify potential areas for growth. With a comprehensive assessment of the market, it equips businesses with the necessary tools to stay ahead of the competition. With this Port equipment Market research report,
Modular Chillers Market to reach USD 6.13 billion by 2026, at a CARG of 6.2% | LG Electronics, Mitsubishi Electric Corporation , Haier Group, Midea Group
Modular Chillers Market to reach USD 6.13 billion by 2026, at a CARG of 6.2% | L …
The Modular Chillers Market Report 2023 by Fortune Business Insights provides a comprehensive overview of the market's latest trends, size, regulations, key players, and strategies. The report offers valuable insights into the market's sales and revenue, product type, applications, regions, and leading players. Modular Chillers Market report also covers key players and competitor analysis, providing a comprehensive understanding of the industry's commercial landscape. The report is useful for gaining insights

All 5 Releases


More Releases for Pharmacies

ePedigree Software Market Analysis By Application: Pharmaceutical Factory, Hospi …
The Insight Partners provides you global research analysis on “ePedigree Software Market” and forecast to 2028. The research report provides deep insights into the global market revenue, parent market trends, macro-economic indicators, and governing factors, along with market attractiveness per market segment. The report provides an overview of the growth rate of the ePedigree Software market during the forecast period, i.e., 2021–2028. ePedigree software is an electronic record, mostly used in
Global Compounding Pharmacies Market, Global Compounding Pharmacies Industry, Co …
The Compounding Pharmacies market is expected to grow from USD X.X million in 2020 to USD X.X million by 2026, at a CAGR of X.X% during the forecast period. The Global Compounding Pharmacies Market report is a comprehensive research that focuses on the overall consumption structure, development trends, sales models and sales of top countries in the global Compounding Pharmacies market. The report focuses on well-known providers in the global
Retail Pharmacies Hospital Pharmacies Long-term Care Pharmacies Mail Order Pharm …
Report Ocean released a report deciphering the Medication Dispensing & Packaging Systems Market report that provides in-depth analysis and crucial insights into key factors that are crucial to the success of the market. The report is a systematic study of the market that provides key statistics on trends, analyst views, competitive landscapes, and key regions markets report is a comprehensive study. In this research report, key business trends and upcoming Medication
Nonerosive Reflux Disease Treatment Market Shares, Strategies and Forecast World …
Patients with classical symptoms of gastroesophageal reflux disease (GERD) with normal esophageal mucosa (i.e. without inflammation) are generally identified to have Nonerosive reflux disease (NERD). The patients with nonerosive reflux disease have no common symptoms. Nonerosive reflux disease patient are one who have normal esophagus during endoscopy but GERD like symptoms. 50 to 70% patients with GERD and more than 49% patients with heartburn tend to have nonerosive reflux disease.
Proglumide Market Report 2018: Segmentation by Product (Tablet, Sapsule, Others) …
Global Proglumide market research report provides company profile for Nanjing Pharmaceutical Factory, Tianyuan Pharmachemical Institute, Hubei Yuancheng Saichuang Technology, Hubei Yikangyuan Chemical, Hubei Prosoerity Galaxy Chemical and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025,
Global Chronic Obstructive Pulmonary Disorder Market by Applications (Hospital P …
ReportsWeb.com has announced the addition of the “Global Chronic Obstructive Pulmonary Disorder Market Size Status and Forecast 2025” The report detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Chronic Obstructive Pulmonary Disorder market, analyzes and researches the Chronic Obstructive Pulmonary Disorder development status and forecast in United States, EU, Japan, China, India and Southeast Asia. This report focuses on the